Lethal Effect of Recombinant Human Fas Ligand in Mice Pretreated with Propionibacterium acnes

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2303-2309

  Tanaka, Masato ^a,b   Suda, Takashi ^a   Yatomi, Takehiro ^c   Nakamura, Norio ^c   Nagata, Shigekazu ^a,b  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; FASLG PROTEIN, HUMAN; LIGAND; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BACTERIAL INFECTION; BIOSYNTHESIS; C3H MOUSE; CELL LINE; CYTOTOXICITY TEST; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER FAILURE; MORTALITY; MOUSE; PROPIONIBACTERIUM ACNES;

ANIMALS; ANTIGENS, CD95; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; FAS LIGAND PROTEIN; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INJECTIONS, INTRAPERITONEAL; LIGANDS; LIVER FAILURE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; PROPIONIBACTERIUM ACNES; RECOMBINANT PROTEINS;

EID: 0031092634     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
2. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75:1169.
3. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
4. Fraser, A., and G. Evan. 1996. A license to kill. Cell 85:781.
5. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235.
6. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in T-cell-lineage. J. Immunol. 154:3806.
7. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. Drummond, and S. Nagata. 1996. Fas ligand in human serum. Nat. Med. 2:317.
8. Leithauser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K.-M. Debatin, P. H. Krammer, and P. Moller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/ tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415.
9. French, L. E., M. Hahne, I. Viard, G. Radlgruber, R. Zanone, K. Becker, C. Müller, and J. Tschopp. 1996. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell. Biol. 335.
10. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
11. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
12. Debatin, K.-M., C. K. Goldman, T. A. Waldmann, and P. H. Krammer. 1993. APO-1 induced apoptosis of leukemia cells from patients with ATL. Blood 81: 2972.
13. Kobayashi, N., Y. Hamamoto, N. Yamamoto, A. Ishii, M. Yonehara, and S. Yonehara. 1990. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA 87:9620.
14. Katsikis, P., E. Wunderlich, C. Smith, L. Herzenberg, and L. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029.
15. Falk, M. H., B. C. Trauth, K.-M. Debatin, C. Klas, C. D. Gregory, A. B. Rickinson, A. Calender, G. M. Lenoir, J. W. Ellwart, P. H. Krammer, and G. W. Bornkamm. 1992. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79:3300.
16. Crispe, I. N. 1994. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1:347.
17. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. G. Roberts, K. M. Denatin, A. Fischer, and J. P. de Villarty. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
18. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
19. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
20. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
21. Adachi, M., S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in the peripheral lymphoid organs and liver. Nat. Genet. 11:294.
22. Adachi, M., S. Suematsu, T. Suda, D. Watanabe, H. Fukuyama, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93:2137.
23. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24:923.
24. Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
25. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
26. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interaction required for programmed cell death after T-cell activation. Nature 373:444.
27. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
28. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
29. Fraziano, M., C. Montesano, I. Sammarco, S. Di Cesare, M. C. Caroleo, M. Mattei, S. Cannata, F. Poccia, A. Belliavia, A. Salerno, and V. Colizzi. 1994. Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer. Clin. Immunol. Immunopathol. 71:265.
30. Allen, R. D., J. D. Marshall, J. B. Roths, and C. L. Sidman. 1990. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 172:1367.
31. Theofilopoulos, A. N., R. S. Balderas, Y. Gozes, M. T. Aguado, L. Hang, P. R. Morrow, and F. J. Dixon. 1985. Association of lpr gene with graft-vs.-host disease-like syndrome. J. Exp. Med. 162:1.
32. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
33. Chu, J. L., P. Ramos, A. Rosendorff, J. Nikolic-Zugic, E. Lacy, A. Matsuzawa, and K. B. Elkon. 1995. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:393.
34. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
35. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777.
36. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129.
37. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand; gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
38. Clare, J. J., M. A. Romanos, F. B. Rayment, J. E. Rowedder, M. A. Smith, M. M. Payne, K. Sreekrishna, and C. A. Henwood. 1991. Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies. Gene 105:205.
39. Enari, M., R. V. Talanian, W. W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723.
40. Enari, M., A. Hase, and S. Nagata. 1995. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14:5201.
41. Tschopp, J. F., G. Sverlow, R. Kosson, W. Craig, and L. Grinna. 1987. High-level secretion of glycosylated invertase in the methylotrophic yeast Pichia pastoris. Biotechnology 5:1305.
42. Fujioka, N., N. Mukaida, A. Harada, M. Akiyama, T. Kasahara, K. Kuno, A. Ooi, M. Mai, and K. Matsushima. 1995. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J. Lenkocyte Biol. 58:90.
43. Katschinski, T., C. Galanos, A. Coumbos, and M. A. Freudenberg. 1994. Gamma interferon mediated Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60:1994.
44. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88.
45. Aggarwal, B. B., R. A. Aiyer, D. Pennica, P. W. Gray, and D. V. Goeddel. 1987. Human tumor necrosis factors: structure and receptor interactions. Ciba Found. Symp. 131:39.
46. Eck, M. J., and S. R. Sprang. 1989. The structure of tumor necrosis factor-α at 2.6 Å resolution. J. Biol. Chem. 264:17595.
47. Eck, M. J., M. Ultsch, E. Rinderknecht, A. M. de Vos, and S. R. Sprang. 1992. The structure of human lymphotoxin (tumor necrosis factor-β) at 1.9-Å resolution. J. Biol. Chem. 267:2119.
48. Takahashi, T., M. Tanaka, J. Ogasawara, T. Suda, H. Murakami, and S. Nagata. 1996. Swapping between Fas and G-CSF receptor. J. Biol. Chem. 271:17555.
49. Dhein, J., P. T. Daniel, B. C. Trauth, A. Oehm, P. Möller, and P. H. Krammer. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166.
50. Suda, T., M. Tanaka, and S. Nagata. 1996. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol. 157:3918.
51. Vignaux, F., E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781.
52. Opdenakker, G., P. M. Rudd, M. Wormald, R. A. Dwek, and J. van Damme. 1995. Cells regulate the activities of cytokines by glycosylation. FASEB J. 9:453.
53. Higuchi, M., M. Oheda, H. Kuboniwa, K. Tomonoh, Y. Shimonaka, and N. Ochi. 1992. Role of sugar chain in the expression of the biological activity of human erythropoietin. J. Biol. Chem. 267:7703.
54. Hubbard, A. L., and H. Stukenbrok. 1979. An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. J. Cell Biol. 83:65.
55. Hopf, U., K.-H. M. zum Büschenfekde, and M. P. Dierich. 1976. Demonstration of binding sites for IgG Fc and the third complement component (C3) on isolated hepatocytes. J. Immunol. 117:639.
56. Möller, P., C. Henner, F. Leithäuser, A. Eichelmann, A. Schmidt, S. Brüderlein, J. Dhein, and P. H. Krammer. 1993. Co-regulation of the APO-1 antigen with ICAM-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B cell lymphomas. Blood 81:2067.